FDA Inspection 1197529 — Oklahoma Blood Institute Arkansas Blood Institute
The FDA completed an inspection of Oklahoma Blood Institute Arkansas Blood Institute on Feb 1, 2023 in Russellville, AR. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 1, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Russellville, AR (United States)